Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain
NCT04034745
·
clinicaltrials.gov ↗
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
lack of funding
Conditions
Pancreatic Cancer
Neuroendocrine Tumors
Cachexia; Cancer
Interventions
DRUG:
telotristat ethyl
Sponsor
Andrew Hendifar, MD
Collaborators
[object Object]